LY-3475070

LY-3475070 is a potent and selective CD73 Inhibitor with IC50 of 28 nM. LY3475070 Alone or in Combination With Pembrolizumab is now under trials for patients with Advanced Cancer.


Cat. No.: EX-A4254	Purity: >98%

For research only, Do not use for Human!

Size	Unit Price (US$)	Stock
50mg	885	In-stock
100mg	1385	In-stock
200mg	2285	In-stock
500mg	3485	In-stock
1g	5250	In-stock
5g	13850	Inquire

Send PO to E-mail:order@excenen.com; or Fax:+86 020 81619670

Discount Request


Synonyms	CD73-IN-3
CAS No.	2375815-63-5
Purity	>98%
Formula	C15H18N4O2
Mol Weight	286.329
Appearance	solid powder
Solubility	Soluble in DMSO
Shelf Life	>2 years if stored properly
Storage	Powder -20℃ 2 years; In solvent -20℃ 1 month;
Shipping	Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Reference:	[1]. Harvey JB, Phan LH, Villarreal OE, Bowser JL. CD73's Potential as an Immunotherapy Target in Gastrointestinal Cancers. Front Immunol. 2020;11:508. Published 2020 Apr 15. doi:10.3389/fimmu.2020.00508 [2]. Robert Dean Dally, et al. Cd73 inhibitors. Patent WO2019168744 A1.
CoA	CoA of LY-3475070


		Search